Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
about
Identification of postoperative prognostic microRNA predictors in hepatocellular carcinomaMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsMicroRNAs as Important Players in Host-hepatitis B Virus InteractionsMicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.MicroRNAs associated with HBV infection and HBV-related HCC.An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma.Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell countsHow microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation.miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loopIncreased glyceraldehyde-3-phosphate dehydrogenase expression indicates higher survival rates in male patients with hepatitis B virus-accociated hepatocellular carcinoma and cirrhosisOLFML3 expression is decreased during prenatal muscle development and regulated by microRNA-155 in pigs.Argonaute 2 and nasopharyngeal carcinoma: a genetic association study and functional analysis.Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.Hsa-mir-1269 genetic variant contributes to hepatocellular carcinoma susceptibility through affecting SOX6.SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition.Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppressionMechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different gradesTripartite containing motif 32 modulates proliferation of human neural precursor cells in HIV-1 neurodegenerationHigh expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma.Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.MicroRNAs in cancer diagnosis and therapy: from bench to bedside.MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection?microRNA therapies in cancer.Non-Coding RNAs in Primary Liver Cancer.Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN.Chitosan combined with molecular beacon for mir-155 detection and imaging in lung cancer.miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma.Clinical significance of microRNA-155 expression in hepatocellular carcinomaDeletion of Mir155 prevents Fas-induced liver injury through up-regulation of Mcl-1.Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell.Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathwayMethylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC.A retrospective study comparing percutaneous and open pedicle screw fixation for thoracolumbar fractures with spinal injuries.Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma.MicroRNA-155 regulates the proliferation, cell cycle, apoptosis and migration of colon cancer cells and targets CBL.Serum miRNAs as Biomarkers for the Diagnosis and Prognosis of Thyroid Cancer: A Comprehensive Review of the Literature.Identification of Sox6 as a regulator of pancreatic cancer development.
P2860
Q21134574-39767F28-0653-4264-A8D0-06D0F88E016DQ26773183-C80DA599-9EF0-4BEA-8374-8F0A4990E93DQ26781737-DA527DDE-1CDA-4D2F-8015-4CEB98EDC7A6Q30439971-1A8C188E-A9D4-434E-8C45-A161B0E4484DQ34284404-9E137FB1-0FB6-44FC-AFFE-08FC3A0C8C6AQ34497012-C1C9CD0E-6DFF-4C24-B25B-A69E24856796Q34598648-778619F2-0D04-46ED-BCE5-5E1064DEE3B8Q34747583-F4CF5938-3244-4AA7-AC34-C88EB4E0871BQ34979339-9C478941-82CA-41DD-8F50-872992DDF76FQ35677296-741B9CE5-625B-4C3F-8722-D554A762852AQ35753997-12DEE5F1-F468-4FBB-9051-0A96D48477F4Q35828544-915C6695-A749-4609-8346-08CF82966217Q35834709-0EB9B371-4696-4CF9-B823-FE62A7DAAC44Q35959329-1A034E75-2989-45E2-9825-D86039C185B6Q36309552-2A1CFF54-55EA-409B-8303-8413ACC46965Q36460528-64783293-C54A-4300-AC74-36E482C44F7CQ36764782-4716E043-690E-4446-9912-8B2B5EE3A950Q36764809-F3829776-18DF-410C-B2EC-082D24F4ED8FQ36799270-1F27149A-E8EC-4DD0-80A5-2C8CB753D1CCQ37059414-529E7A4E-E465-4CF3-881E-7048A6C639FEQ37619833-5351631C-3BC9-4662-8C03-4892038E5241Q38057979-BF550710-C93E-469F-9456-B98AC8F63F70Q38193005-A32E1C2D-3A42-4353-88A3-F70386990314Q38521725-B52052E9-9ABA-4FD3-BFC9-20E43249FE29Q38541359-8A573F17-577F-4298-A96B-4EDE160B510DQ38613525-D3B44A0A-85F1-4D2C-9212-6616F5D67E0BQ38913478-9390D058-6781-4BE5-9AD9-A125EDB2A70EQ38955717-7A084F4D-2A3D-47F8-9260-526E719715EEQ39310720-621334F0-A5AF-4B9C-868A-0A7F1259AF89Q40100942-42EFBA06-A2C0-4B3C-B622-9E8CD17556ADQ40900156-36C8601C-7E3E-4FCC-939C-6A31D5B968A6Q41186907-7EAB8615-49EE-4FE9-8C6C-1C03CCC8D22AQ41384312-7ACA5BF6-100C-4DCF-A671-ECC6EBA9CF45Q41623567-7108BF09-6AB7-4EE6-B351-EDC3BFE1C75CQ42275337-AC0D1B06-7B59-41EF-AA79-18045603BE5EQ42365447-8E83ED49-0D16-42FC-8E5B-5B2D94DC9335Q43147470-1E89BB3E-FA4A-41FA-B94F-F8E71E894B65Q46832510-83BB1F48-DFE1-406C-881D-DF28DD2E71F4Q47145035-A0E0B250-0459-43FE-8E33-1959C16888D5Q48166983-856E190F-CD6D-4A4E-83C3-7EACBCD5C2EB
P2860
Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Aberrant expression of microRN ...... 6 in hepatocellular carcinoma.
@en
Aberrant expression of microRN ...... 6 in hepatocellular carcinoma.
@nl
type
label
Aberrant expression of microRN ...... 6 in hepatocellular carcinoma.
@en
Aberrant expression of microRN ...... 6 in hepatocellular carcinoma.
@nl
prefLabel
Aberrant expression of microRN ...... 6 in hepatocellular carcinoma.
@en
Aberrant expression of microRN ...... 6 in hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Aberrant expression of microRN ...... 6 in hepatocellular carcinoma
@en
P2093
Fengmin Lu
Hui Zhuang
Jingmin Zhao
Malcolm A McCrae
Ting Zhang
Yongfeng Wang
P2860
P304
P356
10.1002/CNCR.26566
P407
P577
2011-10-11T00:00:00Z